Andreia Cruz
Research of anti-fascin drugs in Colorectal Cancer (CCR) at UCAM HiTech- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
UCAM HiTech
-
Spain
-
Business Content
-
1 - 100 Employee
-
Research of anti-fascin drugs in Colorectal Cancer (CCR)
-
Jan 2022 - Present
Cell culture, migration and cell invasion as well as cell viability assays of previously unstudied compounds Cell culture, migration and cell invasion as well as cell viability assays of previously unstudied compounds
-
-
-
UCAM Universidad Cat��lica San Antonio de Murcia
-
Spain
-
Higher Education
-
700 & Above Employee
-
Assistant Researcher
-
Sep 2022 - Jan 2023
Creation of database with different cases of triple negative breast cancer since 2011 from HGUSL using tissue microarray assay (TMA) technique. Cell culture and cell proliferation studies with triple negative breast cancer cells. Creation of database with different cases of triple negative breast cancer since 2011 from HGUSL using tissue microarray assay (TMA) technique. Cell culture and cell proliferation studies with triple negative breast cancer cells.
-
-
-
Universidade do Porto
-
Portugal
-
Higher Education
-
700 & Above Employee
-
Intern in Oncological Pharmacology
-
Jan 2022 - Aug 2022
Study of the impact of Adenosine in Triple Negative Breast Cancer (TNBC) using HPLC technique and studies of cell proliferation and viability.
-
-
Estudante
-
Sep 2019 - Jul 2022
-
-
Education
-
Universidade do Porto
Mestrado em Medicina e Oncologia Molecular, Saúde -
Faculdade de Ciências da Universidade do Porto
Licentiate degree, Bioquímica